Post-Transplant Guidelines for Patients and Physicians
A Guide to Protecting Your Health after Transplant: Recommended Tests and Procedures
provides guidelines that patients and their physicians can use to
schedule long-term follow-up care after a marrow, peripheral blood stem
cell (PBSC) or cord blood transplant.
The guide includes:
Patient Booklet
- Information about side effects that may occur months or years after transplant
- Charts with recommended tests and procedures for patients' six-month, twelve-month and yearly post-transplant check-ups
- Space for patients to record important information about their own post-transplant care
Physicians' Guidelines
- A checklist of recommended screening and preventive practices to help physicians care for their patients post transplant
MYELOMA TERMS YOU SHOULD KNOW
From the Leukemia and Lymphoma Society
(A small Adobe PDF file)
QUESTIONS TO ASK YOUR HEALTHCARE TEAM
From the Leukemia and Lymphoma Society
(A small Adobe PDF file)
MYELOMA GUIDE
From the International Myeloma Foundation
(An Adobe PDF file - about 2.6 MB)
Understanding Medicare Part B:
What Patients need to know about IV Therapy Reimbursement
Cynthia Sherman
Quorum consulting
(Sponsored by the IMF)
May 4, 2007
Click here for Adobe PDF format
Understanding Bone Marrow and Stem Cell
Transplantation
Edward Agura, MD,
Director of the Program in Blood and Marrow
Transplant
Baylor University Medical Center, Dallas, Texas
Feb. 20, 2007
Click here for Adobe PDF format
Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo
Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus
Statement
ANGELA DISPENZIERl, MD; S. VINCENT RAJKUMAR, MD et al
MAYO CLINIC
March, 2007
Click here for Adobe PDF format
Health Care Directives - Who Needs them?
- Maybe You! -
MM FIGHTER! and Attorney Bob Heller
January, 2007
Click here for Adobe PDF format (1.6 MB)
Mayo Clinic Consensus Statement for the Use of
Bisphosphonates in Multiple Myeloma
Martha Q. Lacey, MD et al
August 2006
Click here for Adobe PDF format
What can you do about the high cost of Revlimid?
Some advice from the IMF
Jaw Osteonecrosis in IV Bisposphonate Users: Why it happens and what to do about it
Dr. Dolphine Oda, University of Washington School of Dentistry, October 21, 2006
Click here for Adobe PDF format (11 MB)
Caution Urged in
Bisphosphonate Use for Multiple Myeloma
Mayo Clinic College of Medicine, Aug. 25, 2006 (http://www.cancerpage.com)
Detailed Guide: What is Multiple Myeloma
American Cancer Society
Prevalence of
Monoclonal Gammopathy of Undetermined Significance
Robert
A. Kyle, M.D. et al
New Developments in Multiple Myeloma Management
James R. Berenson, MD.
Coping, Nov/Dec 2005, pg. 44
Return to NWMMFIGHTERS!
home page